MDR- and CYP3A4-Mediated Drug–Drug Interactions

@article{Pal2006MDRAC,
  title={MDR- and CYP3A4-Mediated Drug–Drug Interactions},
  author={Dhananjay Pal and Ashim K Mitra},
  journal={Journal of Neuroimmune Pharmacology},
  year={2006},
  volume={1},
  pages={323-339}
}
P-glycoprotein (P-gp), multiple drug resistance associated proteins (MRPs), and cytochrome P450 3A4 together constitute a highly efficient barrier for many orally absorbed drugs. Multidrug regimens and corresponding drug–drug interactions are known to cause many adverse drug reactions and treatment failures. Available literature, clinical reports, and in vitro studies from our laboratory indicate that many drugs are substrates for both P-gp and CYP3A4. Our primary hypothesis is that transport… CONTINUE READING
56 Citations
102 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 56 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 102 references

Effect of rifampin on steadystate pharmacokinetics of atazanavir and ritonavir in healthy subjects [abst #657

  • D Burger, S Agarwala, M Child
  • 12th Conference on Retroviruses and Opportunistic…
  • 2005
1 Excerpt

Efflux of Depsipeptide FK228 (FR091228, NSC-630176) is mediated by both P-glycoprotein and MRP1

  • JJ Xiao, AB Foraker, PW Swaan, S Liu
  • J Pharmacol EXP Ther
  • 2005
1 Excerpt

Similar Papers

Loading similar papers…